PETV Insider Trading

Insider Ownership Percentage: 24.90%
Insider Buying (Last 12 Months): $51,881.28
Insider Selling (Last 12 Months): $0.00

PetVivo Insider Trading History Chart

This chart shows the insider buying and selling history at PetVivo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PetVivo Share Price & Price History

Current Price: $2.80
Price Change: Price Increase of +0.05 (1.82%)
As of 02/7/2023 05:19 PM ET

This chart shows the closing price history over time for PETV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

PetVivo Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2022John LaiCEOBuy1,000$2.55$2,550.00976,992View SEC Filing Icon  
11/21/2022Robert James RudeliusDirectorBuy860$2.65$2,279.00208,611View SEC Filing Icon  
11/18/2022Robert James RudeliusDirectorBuy1,640$2.56$4,198.40207,751View SEC Filing Icon  
11/17/2022John LaiCEOBuy1,856$2.47$4,584.32974,882View SEC Filing Icon  
11/15/2022John LaiCEOBuy3,000$2.36$7,080.00970,992View SEC Filing Icon  
8/16/2022Robert J CostantinoDirectorBuy5,353$2.52$13,489.566,353View SEC Filing Icon  
7/1/2022John LaiCEOBuy10,000$1.77$17,700.00967,992View SEC Filing Icon  
10/5/2021James Rudolph MartinDirectorBuy1,600$2.46$3,936.00View SEC Filing Icon  
9/13/2021James Rudolph MartinDirectorBuy7,000$3.24$22,680.0085,084View SEC Filing Icon  
9/2/2021Robert J. FolkesCFOBuy10,000$3.91$39,100.003,005View SEC Filing Icon  
8/25/2021James Rudolph MartinDirectorBuy2,000$2.67$5,340.0076,184View SEC Filing Icon  
8/13/2021Scott Mitchell JohnsonDirectorBuy4,000$4.50$18,000.00View SEC Filing Icon  
5/10/2021Scott Mitchell JohnsonDirectorSell1,221$8.54$10,427.34View SEC Filing Icon  
5/4/2021Scott Mitchell JohnsonDirectorSell190$8.78$1,668.20View SEC Filing Icon  
7/16/2020Scott Mitchell JohnsonDirectorBuy5,000$0.80$4,000.00
7/9/2020James Rudolph MartinDirectorBuy38,684$0.51$19,728.84
See Full Table

SEC Filings (Institutional Ownership Changes) for PetVivo (OTCMKTS:PETV)

12.92% of PetVivo stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PETV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

PetVivo Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/24/2023Koshinski Asset Management Inc.15,000$29K0.0%+50.0%0.148%Search for SEC Filing on Google Icon
10/27/2022Asset Dedication LLC14,569$28K0.0%N/A0.145%Search for SEC Filing on Google Icon
10/26/2022Truist Financial Corp107,667$0.21M0.0%-23.0%1.069%Search for SEC Filing on Google Icon
7/22/2022Truist Financial Corp139,803$0.22M0.0%N/A1.399%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.226,137$0.46M0.0%+5.2%2.312%Search for SEC Filing on Google Icon
2/15/2022Kepos Capital LP235,000$0.89M0.1%-27.7%2.408%Search for SEC Filing on Google Icon
1/21/2022Asset Dedication LLC14,569$55K0.0%-50.0%0.150%Search for SEC Filing on Google Icon
11/16/2021Cetera Advisor Networks LLC10,000$27K0.0%N/A0.104%Search for SEC Filing on Google Icon
10/18/2021Asset Dedication LLC29,138$79K0.0%N/A0.302%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
PetVivo logo
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. It is engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The firm's lead product includes Kush, is an intra-articular injection comprised of patented, gel-like biomaterials that is being commercialized for companion animal osteoarthritis. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Minneapolis, MN.
Read More on PetVivo

Today's Range

Now: $2.80
Low: $2.68
High: $2.82

50 Day Range

MA: $2.30
Low: $1.85
High: $2.75

52 Week Range

Now: $2.80
Low: $1.22
High: $2.95


43,392 shs

Average Volume

19,560 shs

Market Capitalization

$28.34 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of PetVivo?

PetVivo's top insider investors include:
  1. John Lai (CEO)
  2. Robert James Rudelius (Director)
  3. James Rudolph Martin (Director)
  4. Robert J Costantino (Director)
  5. Robert J Folkes (CFO)
  6. James Joseph Martin (Director)
  7. Scott Mitchell Johnson (Director)
Learn More about top insider investors at PetVivo.

Who are the major institutional investors of PetVivo?

PetVivo's top institutional shareholders include:
  1. Koshinski Asset Management Inc. — 0.15%
Learn More about top institutional investors of PetVivo stock.

Which institutional investors are buying PetVivo stock?

In the previous quarter, PETV stock was acquired by institutional investors including:
  1. Koshinski Asset Management Inc.
Within the last year, these company insiders have bought PetVivo stock:
  1. John Lai (CEO)
  2. Robert James Rudelius (Director)
  3. James Rudolph Martin (Director)
  4. Robert J Costantino (Director)
  5. Robert J Folkes (CFO)
  6. James Joseph Martin (Director)
  7. Scott Mitchell Johnson (Director)
Learn More investors buying PetVivo stock.